Device Sectors
MC10 stretches Series A funding up to $6M
July 6, 2010 4:35 pm | by Mass High Tech: The Journal of New England Technology | News | CommentsStartup MC10 Inc., which is developing a form of silicon for circuity that can be stretched, bent and twisted, has bumped up its Series A funding from $5.7 million to $6 million.
MDT Editor Sean Fenske highlights companies and technologies seen at the MDandM East 2010 show
July 6, 2010 4:31 pm | by MDTeditor | Videos | CommentsSean Fenske, Editor-in-Chief of Medical Design Technology, gives brief highlights of several innovative technologies seen at the MD&M East 2010 show in NYC. There are several companies featured in this video. They are: SelectConnect Technologies - http://www.selectconnecttech.com/ Nelson...
Reportlinker Adds European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries)
July 6, 2010 10:35 am | by Bio-Medicine.Org | News | CommentsNEW YORK , July 6 /- Reportlinker.com announces that a new market research report is available in its catalogue: European Markets for Gastrointestinal Endoscopic Devices 2010 (15 Countries) http://www.reportlinker.com/p0196554/European-Markets-for-Gastrointestin......
ICAP Ocean Tomo Offers IP Portfolio of Near-Infrared Spectroscopy Technology
July 6, 2010 10:35 am | by Bio-Medicine.Org | News | CommentsCHICAGO , July 6 /- ICAP Ocean Tomo , the intellectual property brokerage division of ICAP plc (IAP.L), has been engaged to sell a patent portfolio of near-infrared spectroscopy technology owned by NIResults Inc. The portfolio includes over 90 issued US and foreign patents and patent...
Koch Institute, N.J. pharma partner on tumor research
July 6, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | News | CommentsMIT's David H. Koch Institute of Integrative Cancer Research is partnering with Ortho-McNeil-Janssen Pharmaceuticals Inc. over cancer research and technology, and specifically the study of tumor microenvironments.
Reportlinker Adds Surgical Equipment Market to 2016 - Emerging Economies to Provide Future Growth Opportunities
July 6, 2010 6:36 am | by Bio-Medicine.Org | News | CommentsNEW YORK , July 6 /- Reportlinker.com announces that a new market research report is available in its catalogue: Surgical Equipment Market to 2016 - Emerging Economies to Provide Future Growth Opportunities http://www.reportlinker.com/p0233679/Surgical-Equipment-Market-to-2016--......
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Optivar®
July 6, 2010 6:36 am | by Bio-Medicine.Org | News | CommentsDETROIT , July 6 /- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD ) has started shipping azelastine ophthalmic solution, 0.05%. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). This sterile...
Biodel Announces Schedule for Presentations at the 37th Annual Meeting and Exposition of the Controlled Release Society
July 6, 2010 6:35 am | by Bio-Medicine.Org | News | CommentsDANBURY, Conn. , July 6 /- Biodel Inc. (Nasdaq: BIOD ) announced today that the following oral and poster presentations describing results from studies of the company's product candidates will be presented during the 37th Annual Meeting and Exposition of the Controlled Release Society in...
Presentations at the Third European Stereotactic Radiation Therapy and Whole Body Radiotherapy Workshop Highlight Clinical Outcomes and Emerging Trends
July 6, 2010 6:34 am | by Bio-Medicine.Org | News | CommentsResults Presented in Spine, Lung, Liver and Prostate Treatment Emphasized the Benefits of Whole Body Radiosurgery SUNNYVALE, Calif. , July 6 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, today announced highlights from the Third European...
Biosensors Comfortable Enough to Wear 24-7
July 5, 2010 8:36 pm | by Massachusetts Institute of Technology | News | CommentsA new kind of sensor could allow for long-term medical monitoring--without direct skin contact.
Targeting a Master Regulator of Disease
July 5, 2010 8:36 pm | by Massachusetts Institute of Technology | News | CommentsDrugmakers place big bets on the emerging science of microRNA.
News briefs from the July issue of Chest
July 5, 2010 8:35 pm | by EurekAlert | News | Comments(American College of Chest Physicians) News briefs from the July issue of Chest feature studies related to how weekend ICU admissions may be linked to increased risk of death and how biomass smoke may be linked to COPD.
Diagnostic blood test can identify rare lung disease
July 5, 2010 8:35 pm | by EurekAlert | News | Comments(University of Cincinnati Academic Health Center) Researchers at the University of Cincinnati and Cincinnati Children's Hospital Medical Center have found that a certain blood test can successfully identify lymphangioleiomyomatosis in some patients, eliminating the need for...
Circadin is Approved in the EU for Treatment of Primary Insomnia in Patients Aged 55 or Over for up to 3 Months
July 5, 2010 3:38 pm | by Bio-Medicine.Org | News | CommentsTEL AVIV, Israel , July 5, 2010 /- Neurim Pharmaceuticals ( http://www.Neurim.com ) confirmed today that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the treatment of primary insomnia in...
New tool to rule out coronary heart disease in primary care
July 5, 2010 3:36 pm | by EurekAlert | News | Comments(Canadian Medical Association Journal) A simple new rule can help primary care physicians rule out coronary heart disease in patients with chest pain, states a study published in CMAJ.
Depression symptoms show little change during the development and progression of Alzheimer's disease
July 5, 2010 3:36 pm | by EurekAlert | News | Comments(Rush University Medical Center) Researchers at Rush University Medical Center found that depressive symptoms show little change during the development and progression of Alzheimer's disease. The study suggests that depression is truly a risk factor for Alzheimer's disease and not...
Heart patients with anxiety disorder experience more cardiovascular events, deaths
July 5, 2010 3:36 pm | by EurekAlert | News | Comments(JAMA and Archives Journals) Among patients with heart disease, anxiety disorders appear to be associated with a higher risk of stroke, heart attack, heart failure and death, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
FDA Approves Strativa Pharmaceuticals' Zuplenz® (ondansetron) Oral Soluble Film
July 2, 2010 8:36 pm | by Bio-Medicine.Org | News | CommentsWOODCLIFF LAKE, N.J. , July 2 /- Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and...
MiMedx Group, Inc. Announces Release Date for Second Quarter Results
July 2, 2010 11:36 am | by Bio-Medicine.Org | News | CommentsMARIETTA, Ga. , July 2 /- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that its results for the second quarter, ended June 30, 2010 , will be released before the opening of...
Watson Completes Acquisition of CRINONE® and PROCHIEVE® Product Line and Shares of Columbia Laboratories
July 2, 2010 11:36 am | by Bio-Medicine.Org | News | CommentsMORRISTOWN, N.J. , July 2 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) today completed the acquisition of the U.S. rights to Columbia Laboratories' CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock. "We are pleased to add...
Spina bifida topic of monthly genetics series
July 2, 2010 7:32 am | by Baylor College of Medicine | News | CommentsSpina bifida, a birth defect that involves the incomplete development of the spinal cord, will be the topic of discussion in a public forum Wednesday, July 14, at The Health Museum of Houston . The forum will feature Dr. Daryl Scott, assistant professor of molecular and human genetics at...
Breast Cancer Patient First in Latin America to Receive Treatment Using Elekta VMAT Planned with Monaco Software
July 2, 2010 6:35 am | by Bio-Medicine.Org | News | CommentsMONTERREY, Mexico and ATLANTA , July 2 /- A 64-year-old female patient with mediastinal metastasis recently became the first in Latin America to receive Elekta VMAT radiotherapy treatment enhanced with Monaco® planning software . Using the arc-based Elekta VMAT delivery method,...
Watson's Generic Prograf® 5 mg Receives FDA Approval
July 2, 2010 6:33 am | by Bio-Medicine.Org | News | CommentsMORRISTOWN, N.J. , July 2 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ), today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Tacrolimus 5 mg capsules,...
Yale spin-off Mira Dx gets $1M from Conn. state fund
July 2, 2010 5:32 am | by Mass High Tech: The Journal of New England Technology | News | CommentsMira Dx Inc., a New Haven, Conn., startup that is making gene-based lab tests for disease susceptibility and response to various therapies, has taken in $1 million from Connecticut Innovations, as part of a $4 million Series A round.
China Medical Technologies to Announce Results for the First Fiscal Quarter Ended June 30, 2010 on August 16, 2010
July 2, 2010 3:34 am | by Bio-Medicine.Org | News | CommentsBEIJING , July 2 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED ), a leading China -based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the first fiscal quarter ("1Q...
